Investigation of Pain Coping Methods and Related Factors in Postmenopausal Women

Sponsor
European University of Lefke (Other)
Overall Status
Completed
CT.gov ID
NCT04543435
Collaborator
(none)
60
1
1.9
31

Study Details

Study Description

Brief Summary

Musculoskeletal pain (MSP) reflects of musculoskeletal conditions related to tissues such as tendons, muscles, ligaments, nerves, and other joint structures. Coping strategies with pain are used to manage the pain and its impacts. The present study aimed to compare active and passive coping strategies used and pain severity in postmenopausal women according to their demographic characteristics. Also, the relationship between pain and coping strategies in postmenopausal women with cMSP will be examined.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Musculoskeletal pain (MSP) reflects of musculoskeletal conditions related to tissues such as tendons, muscles, ligaments, nerves, and other joint structures. If MSP lasts for longer than three months, it becomes chronic. The prevalence of chronic MSP (cMSP) increases with aging and its ratio changes between 35,7% and 49,8%. The previous studies demonstrated the differences in the prevalence of cMSP between men and women. According to most of the studies, older women adults are more vulnerable to experience than men due to some differences in perception of pain such as biological characteristics, their roles in daily life, beliefs or coping strategies with pain.

    Oestrogen has a prominent role in the physiology of muscles, tendons, ligaments, and bones. The decline of this sex hormone during menopause transition could lead to MSP, particularly in the postmenopausal period. Indeed, an increasing rate of cMSP in postmenopausal women has been reported.

    Coping strategies with pain are used to manage the pain and its impacts. Coping with pain requires the self-regulation of individuals using cognitive and behavioral reactions. Dealing with cMSP is a process that can need the making of changes in daily life and activities This study aimed to compare active and passive coping strategies being used and pain severity in postmenopausal women according to their age, marital status, educational status, and exercise habits. Also, subdomains of strategies and subdomains of pain and the relationship between pain and coping strategies in postmenopausal women with cMSP will be examined.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    60 participants
    Observational Model:
    Other
    Time Perspective:
    Cross-Sectional
    Official Title:
    Investigation of Pain Coping Methods and Related Factors in Postmenopausal Women
    Actual Study Start Date :
    Sep 17, 2020
    Actual Primary Completion Date :
    Oct 30, 2020
    Actual Study Completion Date :
    Nov 15, 2020

    Outcome Measures

    Primary Outcome Measures

    1. McGill Pain Questionnaire [15 minutes]

      This tool is used for assesment of pain, namely; body part of pain, timeframe, characteristic and severity of pain. As score increases, pain condition worsens.

    2. Pain Coping Inventory (PCI) [10 minutes]

      This tool is used for assessment of pain coping strategies. The higher score received means that coping strategy is used more.

    3. Timed up and go test [5 minutes]

      This tool is used for assessment of functional mobility. The duration to complete the task (in seconds) is used as a score. As the score increase, the functional mobility decrease.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    50 Years to 69 Years
    Sexes Eligible for Study:
    Female
    Inclusion Criteria:
    • complaints of pain in anywhere of their body.

    • presenting at least 1 year of amenorrhea

    • being between the ages of 50-69 years.

    Exclusion Criteria:
    • have rheumatological, orthopedic and neurological diseases,

    • have compression fractures, malignancies,

    • have a chronic disease that will lead to secondary osteoporosis,

    • have a drug use that will lead to secondary osteoporosis

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 European University of Lefke Mersin Turkey

    Sponsors and Collaborators

    • European University of Lefke

    Investigators

    • Principal Investigator: Beliz B Kaygısız, PT, PhD, European University of Lefke
    • Study Director: Nuray Elibol, Ege University
    • Study Chair: Sevim Acaröz Candan, T.C. ORDU ÜNİVERSİTESİ

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    European University of Lefke
    ClinicalTrials.gov Identifier:
    NCT04543435
    Other Study ID Numbers:
    • ÜEK/47/01/12/1920/05
    First Posted:
    Sep 10, 2020
    Last Update Posted:
    Jan 8, 2021
    Last Verified:
    Jan 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by European University of Lefke

    Study Results

    No Results Posted as of Jan 8, 2021